EMEA-000609-PIP01-09-M01

Key facts

Invented name
Active substance
Recombinant human glutamic acid decarboxylase (rhGAD65)
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0400/2017
PIP number
EMEA-000609-PIP01-09-M01
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
Treatment of Type I Diabetes Mellitus
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Diamyd Therapeutics AB
Decision type
RPM: decision refers to a refusal on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating